据报中芯(00981.HK)年初起囤积半导体生产设备及元件
市传美国商务部或对中芯(00981.HK)施加出口管制,据日经新闻英文版报道,中芯早於数个月前已开始增加半导体生产设备及关键替换元件的库存,以应对相关风险。
报道引述业内人士表示,中芯早於年初起已进入高度戒备状态,从美国、欧洲和日本供应商手中采购的产品量,已超出公司今年需求,采购产品包括蚀刻、光刻、晶圆清洁和测试等须定期更换的零件,又指中芯囤积的易损耗零件已超过一年用量。
消息又指,中芯亦与其他中国晶片制造商合作建立零件分享系统,设立一座中央仓库专门用於储存上述的零件。中芯今年预算资本支出由原定的31亿美元提升至67亿美元,创历史新高。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.